NCT05321199View on ClinicalTrials.gov

Tranexamic Acid During Telescoping Nail Application In Osteogenesis Imperfecta

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

November 30, 2023

Study Completion Date

November 30, 2023

Conditions
Osteogenesis Imperfecta
Interventions
DRUG

Tranexamic acid

Tranexamic acid (TXA) is an antifibrinolytic drug that has been shown to be effective in reducing blood loss and the need for transfusions after several orthopaedic surgeries.

Trial Locations (1)

Unknown

Assiut University Hospitals, Asyut

All Listed Sponsors
lead

Assiut University

OTHER